Metabolic imaging offers promise for improving the characterisation of prostate cancer phenotypes of varying clinical significance. Here, the authors show distinct metabolic features of cribriform and non-cribriform lesions using a variety of imaging techniques across scales.
- Nikita Sushentsev
- Gregory Hamm
- Ferdia A. Gallagher
